Other Articles
|
http://www.bmj.com
(Source: BMJ)
|
http://www.virologyj.com
Background:
The genus Alphavirus includes several potentially lethal human viruses. Additionally, species such as Sindbis virus and Semliki Forest virus are important vectors for gene therapy, vaccination and cancer research, and important models for virion assembly and structural analyses. The genome encodes nine known proteins, including the small '6K' protein. 6K appears to be involved in envelope protein processing, membrane permeabilization, virion assembly and virus budding. In protein gels, 6K migrates as a doublet - a result that, to date, has been attributed to differing degre
|
http://www.biomedcentral.com
Background:
Since a major vaccination campaign in 1994, measles has been eliminated from England. Maintaining elimination requires low susceptibility levels to keep the effective reproduction number R below 1. Since 1995, however, MMR coverage in two year old children has decreased by more than 10%.
Methods:
Quarterly MMR coverage data for children aged two and five years resident in each district health authority in England were used to estimate susceptibility to measles by age. The effective reproduction numbers for each district and strategic health authority were calculated and possible ou
|
http://www.news-medical.net
Bill Gates announced today that the Bill & Melinda Gates Foundation will provide $168.7 million to PATH for its Malaria Vaccine Initiative to develop vaccines for malaria -- a disease that kills thousands of African children every day. (Source: News-Medical News Feed) MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.
|
http://www.guardian.co.uk
World leaders announce plan to end all malaria deaths by 2015 with introduction of vaccine (Source: Guardian Unlimited Science)
|
http://www.webmd.com
CDC: Only 1 in 5 babies aged 6-23 months get recommended, possibly lifesaving flu shots. Adult vaccinations are up, but still too low. (Source: WebMD Health)
|
http://feeds.feedburner.com
UNITED NATIONS (Reuters) - Microsoft founder Bill Gates gave $168.7 million to develop vaccines for malaria, part of $3 billion in funding announced on Thursday to tackle Africa's biggest killer disease. (Source: Reuters: Health)
|
h
Two Alberta Catholic school boards will not be offering a controversial vaccine to Grade 5 girls this fall. (Source: CBC | Health)
|
http://accedasadcuriam.wordpress.com
I’ve been noticing that there’s a recent new(ish) complaint against people that are conc
|
http://www.medpagetoday.com
ATLANTA (MedPage Today) -- Older children as well as the younger set should get routine annual influenza immunization, the CDC has recommended. (Source: MedPage Today Infectious Disease) MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.
|
http://lambdadelta.wordpress.com
The BBC reported yesterday, 24 September, 2008 that Measels, Mumps and Rubella (MMR) vaccine takeup
|
http://lwtc247.wordpress.com
British Labour MP Mary Creagh has proposed forbidding school enrollment to children who have not rec
|
http://lwtc247.wordpress.com
While in the mood for getting some actual information about vaccines (try asking your doctor for an
|
http://www.medscape.com
Britain's cost-effectiveness watchdog NICE has recommended the use of antiviral medications to fight flu in certain circumstances but stressed they should not be a substitute for flu vaccines. Reuters Health Information (Source: Medscape Pharmacist Headlines)
|
http://www.globenewswire.com
NYON, Switzerland, Sept. 25, 2008 (GLOBE NEWSWIRE) -- Mymetics Corporation (OTCBB:MYMX),a vaccine development company, as previously announced on September 23rd 2008, is pleased to announce their preliminary SHIV challenge results on non-human primates previously immunized with the Company's mucosal HIV-AIDS vaccine designed for triggering mucosal protection. The results significantly exceed the Industry standard of 60% to 70% effectiveness to be considered as a promising vaccine, as well as of Mymetics' expectation which was considerable above this level. The Company will continue to
|
http://christieliz.wordpress.com
Vaccine time had arrived, and not without fear. My step dad, a doctor, was commissioned to do the
|
http://feeds.newscientist.com
Inhaling, rather than injecting, vaccines provides added protection against influenza, and could make stocks go further in a pandemic (Source: New Scientist - Bird Flu)
|
http://www.medicalnewstoday.com
Walgreens (NYSE: WAG)(NASDAQ: WAG) pharmacies nationwide will begin offering convenient, affordable access to flu vaccinations. The cost for a flu shot is $24.99 at most Walgreens locations ($30 in select states1). For the first time, most Walgreens locations will also offer FluMist nasal spray as an alternative to the shot for $29.99. Visit walgreens. (Source: Health News from Medical News Today)
|
http://feedproxy.google.com
Dr. James Conway answers the question: 'Should Everyone Get A Flu Vaccine?' (Source: ABC News: Health)
|
http://www.medscape.com
A study in the May 2008 issue of the Journal of Pediatrics looks at vaccine responses in newborns.
Medscape Pediatrics (Source: Medscape PublicHealth Headlines)
|
http://www.foxnews.com
Instead of getting a jab in the arm, scientists say delivering flu vaccines straight into the lungs could be far more effective. (Source: FOXNews.com) MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.
|
http://www.medicalnewstoday.com
Researchers at Georgetown University Medical Center have discovered a new way to limit inflammation caused by the activation of microglia - key immune cells in the brain. Although the role of such cells is to "clean up damage" after injury, they often worsen the damage by releasing toxic inflammatory factors. (Source: Health News from Medical News Today)
|
http://www.immunotherapy-journal.com
Page: 723DOI: 10.1097/CJI.0b013e318183af26Authors: Kronenberger, Konrad *; Noner, Elfriede *[latin sharp s]; Frankenberger, Bernhard *; Wahl, Ulrich +; Dreyling, Martin ++; Hallek, Michael [S]; Mocikat, Ralph * (Source: Journal of Immunotherapy)
|
http://www.immunotherapy-journal.com
Page: 771DOI: 10.1097/CJI.0b013e3181833818Authors: Berntsen, Annika *; Trepiakas, Redas *; Wenandy, Lynn +; Geertsen, Poul F. *; Straten, Per thor +; Andersen, Mads H. +; Pedersen, Anders E. ++; Claesson, Mogens H. ++; Lorentzen, Torben [S]; Johansen, Julia S. [//]; Svane, Inge Marie * + (Source: Journal of Immunotherapy)
|
http://www.obgynsurvey.com
Page: 637DOI: 10.1097/01.ogx.0000333239.22215.57Authors: Dasbach, E J.; Insigna, R P.; Elbasha, E H. (Source: Obstetrical & Gynecological Survey)
|
|
|
